Hazlin John, the Chief Growth Officer of Colgate-Palmolive, has recently exercised stock options and sold a significant number of shares in a transaction that highlights ongoing executive activity at the company. This development is particularly relevant as it comes amid a broader trend of executive transactions within the consumer goods sector.

According to the recent SEC filing dated November 6, 2026, John exercised stock options for 23,376 shares of common stock on November 4, 2026, at a price of $77.04 per share. Following this transaction, he sold the same number of shares at a weighted average price of $99.15, with prices ranging from $98.93 to $99.29.

Colgate-Palmolive, known for its extensive range of personal care and household products, is a major player in the consumer goods industry. The company is incorporated in Delaware and has a fiscal year ending on December 31. Its stock is traded under the symbol CL.

The filing reveals that John now owns 27,021 shares of common stock directly and an additional 5,544 shares through the issuer's 401(k) plan. This indicates a strong commitment to the company, as he continues to hold a substantial amount of stock.

Such executive transactions can influence investor sentiment and raise questions regarding corporate governance. Shareholders often scrutinize the timing and nature of stock transactions by executives, as they can signal confidence in the company's future performance or, conversely, concerns about its direction.

While the filing does not specify what actions may follow this transaction, it underscores the active role of executives in managing their holdings and engaging with the company's stock performance. The SEC filing, accession number 0001225208-26-008751, provides a detailed account of this transaction.